AAPL345.56-1.55 (-0.45%) ▼|ABBV287.93+1.54 (+0.54%) ▲|ABT103.21+0.11 (+0.11%) ▲|ACN245.06+9.90 (+4.21%) ▲|ADBE247.73-0.64 (-0.26%) ▼|AMAT413.18+17.25 (+4.36%) ▲|AMD566.94+6.68 (+1.19%) ▲|AMGN449.95+2.00 (+0.45%) ▲|AMT177.77-6.07 (-3.30%) ▼|AMZN252.54-0.56 (-0.22%) ▼|AVGO347.23+4.90 (+1.43%) ▲|AXP316.12+3.21 (+1.02%) ▲|BA166.71-1.47 (-0.87%) ▼|BAC51.08+0.40 (+0.79%) ▲|BKNG148.00-2.15 (-1.43%) ▼|BLK1,150.65+14.60 (+1.29%) ▲|BMY60.42-1.13 (-1.84%) ▼|BNY148.96+1.38 (+0.94%) ▲|BRK-B544.11+1.12 (+0.21%) ▲|C124.09+1.40 (+1.14%) ▲|CAT715.96+2.65 (+0.37%) ▲|CL91.91-0.26 (-0.28%) ▼|CMCSA21.68-0.17 (-0.76%) ▼|COF204.41+0.97 (+0.47%) ▲|COP150.26+2.30 (+1.55%) ▲|COST983.47-8.67 (-0.87%) ▼|CRM240.71-0.18 (-0.07%) ▼|CSCO109.93-1.45 (-1.30%) ▼|CVS90.66-0.47 (-0.52%) ▼|CVX231.27+3.04 (+1.33%) ▲|DE640.21+0.63 (+0.10%) ▲|DHR234.37+2.37 (+1.02%) ▲|DIS109.14-1.09 (-0.99%) ▼|DUK124.73-0.07 (-0.06%) ▼|EMR167.49+1.22 (+0.73%) ▲|FDX301.65-5.45 (-1.77%) ▼|GD354.34-0.55 (-0.16%) ▼|GE303.32+5.66 (+1.90%) ▲|GEV890.28-4.80 (-0.54%) ▼|GILD159.23+0.15 (+0.09%) ▲|GM81.11+0.57 (+0.71%) ▲|GOOG320.44+3.61 (+1.14%) ▲|GOOGL323.80+3.22 (+1.00%) ▲|GS923.33+11.56 (+1.27%) ▲|HD318.52+0.02 (+0.01%) ▲|HON219.28+0.47 (+0.21%) ▲|IBM251.45+1.20 (+0.48%) ▲|INTC93.80+0.06 (+0.06%) ▲|INTU330.13+1.68 (+0.51%) ▲|ISRG447.28+1.40 (+0.31%) ▲|JNJ270.25+1.52 (+0.57%) ▲|JPM339.65+3.86 (+1.15%) ▲|KO91.83+0.65 (+0.71%) ▲|LIN508.40-0.25 (-0.05%) ▼|LLY1,286.30+4.39 (+0.34%) ▲|LMT629.32+6.33 (+1.02%) ▲|LOW198.75+0.57 (+0.29%) ▲|LRCX254.12+13.27 (+5.51%) ▲|MA613.49+3.64 (+0.60%) ▲|MCD251.60+2.13 (+0.85%) ▲|MDLZ61.87-0.48 (-0.77%) ▼|MDT94.87+0.92 (+0.98%) ▲|META613.34-6.85 (-1.10%) ▼|MMM172.23+0.65 (+0.38%) ▲|MO73.48-0.01 (-0.01%) ▼|MRK140.34-1.49 (-1.05%) ▼|MS189.48+2.57 (+1.38%) ▲|MSFT528.46-2.88 (-0.54%) ▼|MU972.96+44.20 (+4.76%) ▲|NEE81.95-0.47 (-0.57%) ▼|NFLX61.76-0.76 (-1.22%) ▼|NKE37.26-0.30 (-0.80%) ▼|NOW150.63-4.15 (-2.68%) ▼|NVDA217.08-0.87 (-0.40%) ▼|ORCL130.98+0.45 (+0.34%) ▲|PEP132.30-1.20 (-0.90%) ▼|PFE29.38-0.43 (-1.43%) ▼|PG159.22-0.01 (-0.01%) ▼|PLTR194.37-4.36 (-2.19%) ▼|PM202.89+0.27 (+0.13%) ▲|QCOM181.52-2.66 (-1.44%) ▼|RTX197.12+2.52 (+1.30%) ▲|SBUX104.33+1.29 (+1.25%) ▲|SCHW88.86-0.44 (-0.49%) ▼|SO92.58-0.07 (-0.08%) ▼|SPG212.19-0.10 (-0.04%) ▼|T21.04+0.10 (+0.45%) ▲|TMO700.50+7.48 (+1.08%) ▲|TMUS146.74-0.09 (-0.06%) ▼|TSLA401.00-6.46 (-1.59%) ▼|TXN305.50-3.41 (-1.10%) ▼|UBER65.57-0.21 (-0.32%) ▼|UNH412.43+2.04 (+0.50%) ▲|UNP301.70+1.82 (+0.61%) ▲|UPS104.89-1.20 (-1.13%) ▼|USB59.65-0.10 (-0.16%) ▼|V401.72-0.15 (-0.04%) ▼|VZ43.76-0.18 (-0.40%) ▼|WFC84.38+1.72 (+2.07%) ▲|WMT118.74-0.58 (-0.49%) ▼|XOM183.42+3.51 (+1.95%) ▲|AAPL345.56-1.55 (-0.45%) ▼|ABBV287.93+1.54 (+0.54%) ▲|ABT103.21+0.11 (+0.11%) ▲|ACN245.06+9.90 (+4.21%) ▲|ADBE247.73-0.64 (-0.26%) ▼|AMAT413.18+17.25 (+4.36%) ▲|AMD566.94+6.68 (+1.19%) ▲|AMGN449.95+2.00 (+0.45%) ▲|AMT177.77-6.07 (-3.30%) ▼|AMZN252.54-0.56 (-0.22%) ▼|AVGO347.23+4.90 (+1.43%) ▲|AXP316.12+3.21 (+1.02%) ▲|BA166.71-1.47 (-0.87%) ▼|BAC51.08+0.40 (+0.79%) ▲|BKNG148.00-2.15 (-1.43%) ▼|BLK1,150.65+14.60 (+1.29%) ▲|BMY60.42-1.13 (-1.84%) ▼|BNY148.96+1.38 (+0.94%) ▲|BRK-B544.11+1.12 (+0.21%) ▲|C124.09+1.40 (+1.14%) ▲|CAT715.96+2.65 (+0.37%) ▲|CL91.91-0.26 (-0.28%) ▼|CMCSA21.68-0.17 (-0.76%) ▼|COF204.41+0.97 (+0.47%) ▲|COP150.26+2.30 (+1.55%) ▲|COST983.47-8.67 (-0.87%) ▼|CRM240.71-0.18 (-0.07%) ▼|CSCO109.93-1.45 (-1.30%) ▼|CVS90.66-0.47 (-0.52%) ▼|CVX231.27+3.04 (+1.33%) ▲|DE640.21+0.63 (+0.10%) ▲|DHR234.37+2.37 (+1.02%) ▲|DIS109.14-1.09 (-0.99%) ▼|DUK124.73-0.07 (-0.06%) ▼|EMR167.49+1.22 (+0.73%) ▲|FDX301.65-5.45 (-1.77%) ▼|GD354.34-0.55 (-0.16%) ▼|GE303.32+5.66 (+1.90%) ▲|GEV890.28-4.80 (-0.54%) ▼|GILD159.23+0.15 (+0.09%) ▲|GM81.11+0.57 (+0.71%) ▲|GOOG320.44+3.61 (+1.14%) ▲|GOOGL323.80+3.22 (+1.00%) ▲|GS923.33+11.56 (+1.27%) ▲|HD318.52+0.02 (+0.01%) ▲|HON219.28+0.47 (+0.21%) ▲|IBM251.45+1.20 (+0.48%) ▲|INTC93.80+0.06 (+0.06%) ▲|INTU330.13+1.68 (+0.51%) ▲|ISRG447.28+1.40 (+0.31%) ▲|JNJ270.25+1.52 (+0.57%) ▲|JPM339.65+3.86 (+1.15%) ▲|KO91.83+0.65 (+0.71%) ▲|LIN508.40-0.25 (-0.05%) ▼|LLY1,286.30+4.39 (+0.34%) ▲|LMT629.32+6.33 (+1.02%) ▲|LOW198.75+0.57 (+0.29%) ▲|LRCX254.12+13.27 (+5.51%) ▲|MA613.49+3.64 (+0.60%) ▲|MCD251.60+2.13 (+0.85%) ▲|MDLZ61.87-0.48 (-0.77%) ▼|MDT94.87+0.92 (+0.98%) ▲|META613.34-6.85 (-1.10%) ▼|MMM172.23+0.65 (+0.38%) ▲|MO73.48-0.01 (-0.01%) ▼|MRK140.34-1.49 (-1.05%) ▼|MS189.48+2.57 (+1.38%) ▲|MSFT528.46-2.88 (-0.54%) ▼|MU972.96+44.20 (+4.76%) ▲|NEE81.95-0.47 (-0.57%) ▼|NFLX61.76-0.76 (-1.22%) ▼|NKE37.26-0.30 (-0.80%) ▼|NOW150.63-4.15 (-2.68%) ▼|NVDA217.08-0.87 (-0.40%) ▼|ORCL130.98+0.45 (+0.34%) ▲|PEP132.30-1.20 (-0.90%) ▼|PFE29.38-0.43 (-1.43%) ▼|PG159.22-0.01 (-0.01%) ▼|PLTR194.37-4.36 (-2.19%) ▼|PM202.89+0.27 (+0.13%) ▲|QCOM181.52-2.66 (-1.44%) ▼|RTX197.12+2.52 (+1.30%) ▲|SBUX104.33+1.29 (+1.25%) ▲|SCHW88.86-0.44 (-0.49%) ▼|SO92.58-0.07 (-0.08%) ▼|SPG212.19-0.10 (-0.04%) ▼|T21.04+0.10 (+0.45%) ▲|TMO700.50+7.48 (+1.08%) ▲|TMUS146.74-0.09 (-0.06%) ▼|TSLA401.00-6.46 (-1.59%) ▼|TXN305.50-3.41 (-1.10%) ▼|UBER65.57-0.21 (-0.32%) ▼|UNH412.43+2.04 (+0.50%) ▲|UNP301.70+1.82 (+0.61%) ▲|UPS104.89-1.20 (-1.13%) ▼|USB59.65-0.10 (-0.16%) ▼|V401.72-0.15 (-0.04%) ▼|VZ43.76-0.18 (-0.40%) ▼|WFC84.38+1.72 (+2.07%) ▲|WMT118.74-0.58 (-0.49%) ▼|XOM183.42+3.51 (+1.95%) ▲|
13.7 C
New York
Wednesday, October 28, 2026

Tag: rule

newsFORsourcecompanycontentinformation1releasesmarket

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 10,200 shares of its common stock to fourteen newly-hired employees, with a grant date of August 5, 2025 (the "Grant Date"). The restricted stock units were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of each individual's employment compensation and were granted as an inducement material to his or her acceptance of employment with TELA Bio.

eHealth, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

AUSTIN, Texas, Aug. 8, 2025 /PRNewswire/ -- eHealth, Inc. (Nasdaq: EHTH) (ehealth.com), a leading private online health insurance marketplace (the "Company"), today announced that on...

Faraday Future Announces the Upcoming Special Meeting to Enable Rapid Execution of the Second Chapter of the Bridge Strategy and Adhere to Prudent Issuance...

Faraday Future Announces the Upcoming Special Meeting to Enable Rapid Execution of the Second Chapter of the Bridge Strategy and Adhere to Prudent Issuance

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CAMBRIDGE, Mass., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that the company granted non-statutory stock options to new employees. Fulcrum granted stock options to purchase shares of the company’s common stock pursuant to the company’s 2022 Inducement Stock Incentive Plan, as amended, or the plan, as an inducement material to the new employees entering into employment with Fulcrum in accordance with Nasdaq Listing Rule 5635(c)(4).

PetSmart Prices Notes Offering

PHOENIX, Aug. 8, 2025 /PRNewswire/ -- PetSmart LLC ("PetSmart") announced today that, together with its wholly-owned subsidiary, PetSmart Finance Corp. (the "Co-Issuer" and, together...

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that, on August 4, 2025, the Compensation Committee of Vera’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 99,000 shares of Class A common stock and restricted stock units (RSUs) underlying 48,200 shares of Class A common stock to eight (8) new employees under the Vera Therapeutics, Inc. 2024 Inducement Plan (Inducement Plan). The Compensation Committee approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4).

Amwell makes grant to new employees under inducement plan

Amwell makes grant to new employees under inducement plan

Simón Bolívar’s Long-Lost Firearm Surfaces for Auction as Venezuela Captures Global Headlines

Bidding War Expected for Legendary Firearm as Eyes Turn to Caracas BEDFORD, Texas, Aug. 8, 2025 /PRNewswire/ -- An ornate presentation flintlock owned by South...

Saks Global Announces Early Settlement of the Exchange Offer and Consent Solicitation, Completing Previously Announced $600 Million Financing Package

Company received $300 million in connection with the Exchange Offer on August 8, 2025 Holders of approximately 98% of the aggregate principal amount of the...

Calumet Reports Second Quarter 2025 Results

Second quarter 2025 net loss of $147.9 million, or basic loss per common share of $1.70 per shareSecond quarter 2025 Adjusted EBITDA with Tax...

Form 8.3 – AXA INVESTMENT MANAGERS: Just Group Plc

FORM 8.3

Aveanna Healthcare Holdings Announces Second Quarter Financial Results and Revised 2025 Outlook

ATLANTA, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a leading, diversified home care platform focused on providing care to medically complex, high-cost patient populations, today announced financial results for the three and six-month periods ended June 28, 2025.

Primo Brands Reports Second Quarter 2025 Results

Revises full year 2025 Net Sales, Adjusted EBITDA, and Adjusted Free Cash Flow guidanceReaffirms cost synergy capture targets of $200 million in 2025; $300...

Ecovyst Reports Second Quarter 2025 Results

WAYNE, Pa., Aug. 7, 2025 /PRNewswire/ -- Ecovyst Inc. (NYSE: ECVT) ("Ecovyst" or the "Company"), a leading integrated and innovative global provider of advanced...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsRule

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers